These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39248402)

  • 1. Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study.
    Guo Y; Shi S; Zhao J; Wang C; Liu Z; Fu S; Chen N; Li G; Wang L; Ni Z; Zhang H; Lai L; Lv J; Zhang H
    Ren Fail; 2024 Dec; 46(2):2398826. PubMed ID: 39248402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.
    Oruc A; Sumnu A; Turkmen A; Basturk T; Cebeci E; Turgutalp K; Cetinkaya H; Uzerk Kibar M; Seyahi N; Tatar E; Ergul M; Derici Ü; Aylı MD; Pınar M; Bakar B; Kazancıoglu R; Yıldız A; Dirim AB; Yılmaz Z; Turkmen K; Tunca O; Koc M; Kutlay S; Micozkadıoglu H; Azak A; Boztepe B; Ustundag S; Şafak Ozturk S; Unsal A; Karadag S; Sahin G; Yenigun EC; Eren N; Gullulu M; Gursu M; Ozturk S
    Ren Fail; 2024 Dec; 46(1):2341787. PubMed ID: 38637275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X; Ma F; Bai M; Wang Y; Jia Q; Dong R; Liu C; Sun S
    Ren Fail; 2021 Aug; 43(1):1180-1187. PubMed ID: 34376108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
    Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    Canney M; Barbour SJ; Zheng Y; Coppo R; Zhang H; Liu ZH; Matsuzaki K; Suzuki Y; Katafuchi R; Reich HN; Cattran D; ;
    J Am Soc Nephrol; 2021 Feb; 32(2):436-447. PubMed ID: 33514642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
    J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
    Tan L; Tang Y; Peng W; Mathew BS; Qin W
    Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
    JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
    Rauen T; Eitner F; Fitzner C; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JF; Hilgers RD; Floege J;
    N Engl J Med; 2015 Dec; 373(23):2225-36. PubMed ID: 26630142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
    Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
    Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analysis of treatment of Immunoglobulin A-nephropathy].
    Dobronravov VA; Kochoyan ZS; Muzhetskaya TO; Lin DI
    Ter Arkh; 2020 Jul; 92(6):23-32. PubMed ID: 33346489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: STOP immunosuppression in IgA nephropathy?
    Pozzi C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1766-1770. PubMed ID: 27515694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.
    Barbour SJ; Cattran DC; Kim SJ; Levin A; Wald R; Hladunewich MA; Reich HN
    Kidney Int; 2013 Nov; 84(5):1017-24. PubMed ID: 23739233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.